ArticleCancer medicine2024

A Phase 1 Study of ABI-009 (Nab-sirolimus) in Combination With Temozolomide and Irinotecan in Pediatric Patients With Recurrent or Refractory Solid Tumors, Including CNS Tumors-A Children's Oncology Group Pediatric Early Phase Clinical Trial Network Study ADVL1514.

Stuart L Cramer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.